What is endocrine pancreatic cancer?
Endocrine Pancreatic Cancer, also known as islet cell cancer, is a rare cancer. Only about 5 percent of the more than 43,000 annual cases of pancreatic cancers begin in the islet cells. When islet cells become neoplastic, they may make too much insulin and other types of hormones. Different types of endocrine pancreatic cancer have different names. The three most common types are:
Who is most likely to have endocrine pancreatic
Endocrine pancreatic cancer is more common among men and African-Americans. Risk factors include smoking, long-standing diabetes, chronic pancreatitis, and certain hereditary conditions including hereditary pancreatitis, multiple endocrine neoplasia type 1 syndrome, hereditary nonpolyposis colon cancer (HNPCC; Lynch syndrome), von Hippel-Lindau syndrome, ataxia-telangiectasia, and the familial atypical multiple mole melanoma syndrome. Other risk factors include a family history of pancreatic cancer, older age, and obesity. Exposure to certain pesticides, dyes, or chemicals related to gasoline is another risk.
What characterizes endocrine pancreatic cancer?
Endocrine pancreatic cancer is difficult to detect early because its symptoms are similar to other illnesses and because the pancreas is hidden behind other organs. Often, this type of cancer is not detected until it has spread. Symptoms include abdominal pain, diarrhea, chronic fatigue, fainting, or weight gain without eating too much. These symptoms, coupled with the risk factors described earlier, warrant a trip to see a doctor as soon as possible.
How does the pathologist diagnose endocrine pancreatic
Your primary care physician will order blood and urine tests for the pathologist to examine for the amounts of endocrine hormones in the body. Your medical team also may order imaging tests such as chest x-rays; CT, PET or MRI scans; or endoscopic ultrasound (EUS) to view inside the body.
Laparoscopy allows physicians to view inside the body using a thin, lighted tube inserted through small incisions in the abdominal wall. Endoscopic retrograde cholangiopancreatography (ERCP) examines the bile ducts for narrowing or blockages sometimes associated with pancreatic cancer. Biopsy specimens, or tissue samples, can be gathered during both of these procedures.
What else does the pathologist look for?
The pathologist reviews the biopsy specimens and the results of all tests to make a diagnosis. If cancer is found, the pathologist will determine the stage of the cancer. Stage 1 endocrine pancreatic cancers are small and confined to the pancreas, and stage 4 tumors have spread beyond areas near the pancreas. Stages 2 and 3 describe conditions in between these two extremes. The chance of recovery depends on the type of endocrine pancreatic cancers, how far the cancer has spread, and your overall health.
How do doctors determine what treatment will
The pathologist consults with your primary care physician or specialist after reviewing the test results and determining the stage of the cancer. Together, using their combined experience and knowledge, they determine treatment options most appropriate for your condition. It's important to learn as much as you can about your treatment options and make the decision that’s right for you.
What kinds of treatments are available for endocrine
Endocrine pancreatic cancer can be treated with surgery, chemotherapy, hormone therapy, or a combination of these methods. In addition, patients may have treatment to control pain or ease emotional or practical problems.
Surgery, the most common treatment, removes the cancerous tumor, part or all of the pancreas, and sometimes other tissues or organs. Surgical options include:
If the cancer has spread and cannot be removed, other surgical procedures may be used to relieve pain and other symptoms.
If the cancer has spread outside the pancreas—or if there is a chance it has—your doctor may recommend chemotherapy. This treatment delivers drugs throughout the body, and may slow the cancer's progression and reduce pain. Systemic chemotherapy delivers drugs throughout the body, while regional chemotherapy directs the drugs into a particular organ or area of the body, such as the pancreas or abdomen.
The most commonly used chemotherapy drug is 5-fluorouracil (5-FU). Recent studies, however, show gemcitabine to be more effective. Further studies comparing the effectiveness of these two drugs in treating various types of cancers are in progress, as well as other studies combining these two drugs with each other or other chemotherapy drugs.
Hormone therapy may stop cancer cells from growing and relieve pain and other symptoms caused by excessive hormone production. Octreotide is the most commonly used hormone-related medication. Scientists continue to investigate the effectiveness of other treatment approaches.
Clinical trials of new treatments for endocrine pancreatic cancer may be found at www.cancer.gov/clinicaltrials. These treatments are highly experimental in nature but may be a potential option for advanced cancers. Some trials may involve biologic therapy, which uses the natural defenses of the immune system to fight cancer.
What kinds of questions should I ask my doctors?
Ask any question you want. There are no questions you should be reluctant to ask. Here are a few to consider:
DEFINITION OF TERMS
Endocrine: Relating to the endocrine glands and the hormones, such as insulin, which are secreted by those glands.
Islet Cells: Pancreatic cells that produce insulin and other hormones.
Malignant: Cancerous and capable of spreading.
Pathologist: A physician who examines tissues and fluids to diagnose disease in order to assist in making treatment decisions.
This information was developed by the College of American Pathologists’ Public Affairs Committee in conjunction with the College’s Cancer Committee and Council on Scientific Affairs. The College is providing this information to help you better understand your health. Ultimately any decisions you make about your health, however, should be between you and your doctor.